Search

Author/Creator Samjoo, Imtiaz A.

1. Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses. (2nd November 2021)

Authors:
Samjoo, Imtiaz A.; Worthington, Evelyn; Haltner, Anja; Spin, Paul; Drudge, Christopher; Cameron, Chris; Brennan, Róisín; Dahlke, Frank; Adlard, Nicholas
Journal:
Current medical research and opinion
Issue:
Volume 37:Number 11(2021)
Page Start:
1933
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. (3rd October 2021)

Authors:
Martin, Tom; Usmani, Saad Z.; Schecter, Jordan M.; Vogel, Martin; Jackson, Carolyn C.; Deraedt, William; Tian, Hong; Yeh, Tzu-min; Banerjee, Arnob; Pacaud, Lida; Garrett, Ashraf; Haltner, Anja; Cameron, Chris; Van Sanden, Suzy; Diels, Joris; Valluri, Satish; Samjoo, Imtiaz A.
Journal:
Current medical research and opinion
Issue:
Volume 37:Number 10(2021)
Page Start:
1779
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis. (2nd July 2020)

Authors:
Samjoo, Imtiaz A.; Worthington, Evelyn; Haltner, Anja; Cameron, Chris; Nicholas, Richard; Rouyrre, Nicolas; Dahlke, Frank; Adlard, Nicholas
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 7(2020)
Page Start:
1157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma. (3rd October 2022)

Authors:
Costa, Luciano J.; Hari, Parameswaran; Berdeja, Jesus G.; De Stefano, Valerio; Gay, Francesca; Hooper, Becky; Bartlett, Meaghan; Haltner, Anja; Rosta, Emily; Kumar, Shaji; Martin, Thomas; Mateos, Maria-Victoria; Moreau, Philippe; Usmani, Saad Z.; Olyslager, Yunsi; Schecter, Jordan M.; Roccia, Tit...
Journal:
Current medical research and opinion
Issue:
Volume 38:Number 10(2022)
Page Start:
1759
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis. (2nd July 2020)

Authors:
Samjoo, Imtiaz A.; Worthington, Evelyn; Haltner, Anja; Cameron, Chris; Nicholas, Richard; Dahlke, Frank; Adlard, Nicholas
Journal:
Current medical research and opinion
Issue:
Volume 36:Number 7(2020)
Page Start:
1145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. (2nd January 2023)

Authors:
Martin, Tom; Usmani, Saad Z.; Schecter, Jordan M.; Roccia, Tito; Jackson, Carolyn C.; Deraedt, William; Yeh, Tzu-min; Banerjee, Arnob; Pacaud, Lida; Garrett, Ashraf; Bartlett, Meaghan; Haltner, Anja; Van Sanden, Suzy; Diels, Joris; Valluri, Satish; Samjoo, Imtiaz A.
Journal:
Current medical research and opinion
Issue:
Volume 39:Number 1(2023)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗